Trial Summary Table

Trial Name	Phase	Start Date	Sponsors	Countries	Population	Candidate(s)	Status	Expected Completion Date
CONRAD 120	I	Saturday, June 30, 2012	CONRAD	United States of America	Women	1% tenofovir gel	Completed	December 2012
CONRAD A10-114	I	Saturday, March 31, 2012	CONRAD	United States of America, Dominican Republic	Women	1% tenofovir gel, DMPA	Completed	March 2014
CONRAD A13-128	I	Wednesday, October 1, 2014	CONRAD	United States of America, Dominican Republic	Women	TFV ring, TFV/LNG ring	Completed	December 2015
CONRAD A15-138/ ENRICH	I	Tuesday, September 5, 2017	CONRAD	United States of America, Dominican Republic	Men	TFV/LNG ring	Completed	December 2018
CONRAD A15-140	I	Thursday, April 7, 2016		United States of America	Women	TFV ring, TDF/FTC (Truvada)	Completed	August 2016
CONRAD A18-146	I	Tuesday, December 11, 2018	CONRAD	United States of America	Women	Elvitegravir (EVG), F/TAF	Completed	March 2019
CONRAD B17-144	II	Thursday, December 6, 2018		Kenya	Women	TFV/LNG ring, TFV ring	Ongoing	April 2020
CONRAD Cellulose Sulfate	III	Sunday, July 31, 2005	CONRAD, USAID, Bill and Melinda Gates Foundation	India, Uganda, Benin	Women		Stopped Early	March 2007
DREAM-01	I	Wednesday, October 5, 2016	NIAID (DAIDS-ES: 12067)	United States of America, Malawi	Men		Ongoing	May 2019
EMOTION - Enhancing Microbicide Uptake in High-Risk End Users	Other	Monday, July 4, 2016	USAID, CONRAD	Kenya, South Africa, Zimbabwe	Women		Ongoing	July 2020

You are here